The only pharmacologically induced method to achieve Therapeutic Hypothermia.
BioPharma IND-ready to initiate Ph-1 study in patients at University of Pittsburgh. HBN-1 is only pharmacologic method to reduce & maintain core body temp which is Amer Heart Assoc recommended treatment for resuscitated post-cardiac arrest. Over $1M in Founder $ invested as well as $3M NIH award for preclin program. Multi-$B global mkt. Pt study yields efficacy to trigger exit in late 2019, or option to continue to add further value.